Kang-Hsing FAN MD

Specialist of genitourinary tract cancer and head and neck cancer

Proton therapy, radiotherapy for prostate cancer and genitourinary tract cancer, radiotherapy for head and neck cancer


With the development of medical technology, many treatments have been improved greatly. Currently, medical professionals are engaged in not only treating cancer, but also preserving the functions of organs. Nowadays, treatments for throat and bladder cancer allow the organs to maintain their functions, so patients have no trouble living their daily or professional lives. Some patients with prostate cancer do not even feel any difference before and after treatment. It is great that the Tumor Therapy Team at Linkou Chang Gung Memorial Hospital has entered a new stage. With the effort of all team members and the new proton therapy technology, our team can provide better assistance and care for patients.


Proton Therapy, Radiotherapy for Prostate Cancer and Urinary Tract Cancer, Radiotherapy for Head and Neck Tumors

Treatment Cases

More than 500 cases of genitourinary cancer and head and neck cancer

Tumor control rate is over 90% of prostate cancer


2001/09 - 2009/06, MD, Department of Medicine, Taipei Medical University


Resident Physician, Linkou Chang Gung Memorial Hospital

Current Appointment

Attending Physician, Linkou Chang Gung Memorial Hospital

  1. Preliminary Treatment Results of Intensity-Modulated Radiotherapy for Prostate Cancer, Chang Gung Med J. 2006 May-Jun;29(3):313-24.
  2. Combined Modality Treatment for Advanced Oral Tongue Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):453-61
  3. Adjuvant androgen deprivation lost its benefit after premature termination: an experience of combined modality treatment on prostate cancer. Chang Gung Med J. 2009 Sep-Oct;32(5):526-34
  4. Treatment rults of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiat Oncol Biol Phys. 2010 July 15;77(4):1024-9
  5. Adjuvant and salvage radiotherapy for urothelial cell carcinoma of the upper urinary tract: experience in a single institution. Chang Gung Med J. 2012 May-Jun;35(3):247-54.
  6. Pre-radiotherapy PSA level as a predictor for biochemical control in prostate cancer patients receiving radiotherapy after radical prostatectomy. Biomed J. 2013 Mar-Apr;36(2):71-6.
  7. Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors. (SCI) PLoS One. 2014 Feb 24;9(2):e86922.
  8. Clinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies. PLoS One. 2015 Sep 3;10(9):e0136918. doi: 10.1371/journal.pone.0136918. eCollection 2015.